London, United Kingdom, Friday 11 April 2014: New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).[1] As part of a compassionate use program, 104 …

READ FULL ARTICLE Curated publisher From virtualpressoffice.easl.eu